India Seeks To Revive National Vaccine Production Program
This article was originally published in PharmAsia News
Executive Summary
Indian authorities are considering a revival of the nation's vaccine-production program to make up for recent declines due to failures to meet international standards. Two Indian companies lost sanction by the World Health Organization because they failed to meet good manufacturing practices standards. But if the government is to revive vaccine production for bacillus calmetteguerin, cholera, diptheria, rabies, tetanus and typhoid, it may have to invest $5 billion in the effort. Among the suggestions is establishment of state-run manufacturing companies to produce vaccines companies complying with World Health Organization standards. (Click here for more